Update in lung Cancer treatment: Immuno-Oncology and target therapies

Version imprimable
May 15, 2017
Paul Wheatley-Price

For the CRCHUM conference taking place on May 19, 2017, Paul Wheatley-Price, Medical Oncologist at the Ottawa Hospital, will speak about lung Cancer, its prevalence, characteristics and updates to current treatments including immunotherapy and targeted therapies.

About Paul Wheatley-Price

His research interests are in thoracic oncology, with an emphasis on systemic therapy in challenging clinical scenarios, and in the rare cancer types mesothelioma and thymoma. He is active in lung cancer advocacy, in June 2016 becoming President of Lung Cancer Canada, a national charity supporting patient and caregivers lung cancer, and promoting advocacy and research. He is also a young leader in medicine, having recently completed the OMA Physician Leadership Development Program, and in the summer of 2016 became Deputy Division Head of Medical Oncology.
 

Guest of AstraZeneca 

This conference will be presented in English.

Friday, May 19, 2017, at Noon.
Auditorium of the CRCHUM , R05.210 and R05.220
900 Saint-Denis Street, 5th floor 
Montréal (Quebec)  H2X 0A9


Paul Wheatley-Price,  MBChB, MRCP (UK)
Department of Medicine, Division of Medical Oncology
Ottawa Hospital Cancer Centre
 

About CRCHUM Conferences

The CRCHUM Conferences are free weekly meetings featuring renowned scientific speakers from various disciplines. These conferences are accredited by the Royal College of Physicians and Surgeons of Canada as continuing professional development activities. The CRCHUM conferences are made possible thanks to the financial support of our partners: AstraZeneca, GSK, Lilly, Merck, Roche & Servier.
 

About our scientific activities

Schedule of the Conferences at the CRCHUM

Schedule of scientific activities at the CRCHUM